Recombinant Human CLDN19 Protein，GST

CLDN19 (Claudin-19) is a member of the claudin family of transmembrane proteins, which are crucial components of tight junctions that regulate paracellular permeability in epithelial tissues. Research has shown that CLDN19 plays a significant role in maintaining the integrity of the blood-brain barrier as well as being involved in renal function, particularly in the proximal tubule of the kidney. Mutations in the CLDN19 gene are linked to various pathologies, including a rare genetic disorder known as hypomagnesemia with secondary epilepsy and other neurological problems. Given its importance in cell adhesion and barrier function, CLDN19 is a target of interest for studying both normal physiological processes and disease mechanisms. In recent years, efforts have focused on elucidating the structure and function of CLDN19 through the production of recombinant proteins, which can provide insights into its molecular interactions and potential therapeutic implications. Advanced techniques such as crystallography and biophysical characterization of CLDN19 recombinant proteins allow for a deeper understanding of its role in epithelial barrier function, as well as its potential as a biomarker or therapeutic target in conditions associated with altered tight junction dynamics. Overall, the study of CLDN19 recombinant protein is essential for uncovering the cellular and molecular bases of disorders linked to its dysfunction, paving the way for innovative clinical strategies.